Skip to main content

Day: May 7, 2025

Study shows patients treated with Smith+Nephew’s CARTIHEAL™ AGILI-C™ Cartilage Repair Implant have an 87% lower relative risk of Total Knee Arthroplasty or Osteotomy at 4 years¹*

The CARTIHEAL Implant will be featured at the Arthroscopy Association of North America Annual Meeting (AANA 2025) this week Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, today announces encouraging results for its CARTIHEAL AGILI-C Cartilage Repair Implant from a recent multicentre randomised controlled trial (RCT) treating knee cartilage defects. When compared to the current surgical standard of care,* the implant demonstrated: Superior pain relief: Patients treated with the CARTIHEAL AGILI-C Implant reported significantly better knee pain relief, and quality of life improvements over a 4-year period.1-3 ** Superior functional gains: Patients treated with the CARTIHEAL Implant reported superior improvements in performing activities related to daily living, sport and recreation at 2 and 4 years. 1-3Different...

Continue reading

Procedure for the Payment of AB Kauno Energija Dividends for 2024

The General Meeting of Shareholders of AB Kauno Energija (identification code 235014830, address Raudondvario str. 84, Kaunas, LT-47179) that has been held on 28 April 2025 decided to allocate EUR 0.02435 dividend per share. Dividends are paid out from 23 May 2025 in the following order: to the shareholders, whose AB Kauno Energija shares are accounted by a financial brokerage company or credit institutions, which provide securities accounting services, the dividend amount, after deduction of Personal or Corporate withholding income tax applicable by the laws of Lithuania, will be transferred to the shareholders’ accounts held with a respective financial brokerage company or credit institution; to the shareholders, whose AB Kauno Energija shares on behalf of the Company are accounted by the authorised custodian...

Continue reading

Pyxis Tankers Announces Loan Commitment for Potential Fleet Expansion

Maroussi, Greece – May 7, 2025 – Pyxis Tankers Inc. (the “Company”) (NASDAQ Cap Mkts: PXS), an international shipping company, announced today that it had signed a commitment letter with an existing bank for a “hunting license” loan facility of up to $45 million (the “Facility”) in order to finance the potential acquisition of up to two modern vessels, consisting of product tankers between 45-115K dwt. and/or  dry bulk carriers between 60-85K dwt. Advances under the Facility, which can be as much as 62.5% of vessel purchase value, can be drawn-down anytime for a period of  up to 18 months after closing of the Facility, which is expected to occur during June, 2025. The balance of the purchase consideration would consist of cash equity on hand from the Company. Borrowings under the Facility would have an average interest rate of SOFR + 1.9%....

Continue reading

Cycurion’s W. Eric Singleton to Speak at the Armed Forces Communication and Electronics Association’s TechNet Cyber 2025 on Active Cyber Defense Innovation

MCLEAN, Va., May 07, 2025 (GLOBE NEWSWIRE) — Cycurion (Nasdaq: CYCU) (“Cycurion” or the “Company”), a trusted leader in IT cybersecurity solutions and AI, announces that W. Eric Singleton, Vice President of Operations, will be a featured speaker at the Armed Forces Communications and Electronics Association’s (AFCEA) TechNet Cyber 2025, one of the premier events for cyber leaders in the Department of Defense, intelligence community, and defense industry. Mr. Singleton’s presentation is titled, “ARx: Active Cyber Defense & Deception Platform, a transformative approach to cyber defense that turns attacker reconnaissance into a costly and intelligence-yielding operation.” With over two decades of experience in national security and technology leadership, Mr. Singleton will highlight how ARx is reshaping cyber defense for modern...

Continue reading

Florida Healthcare Leader Embraces Daxor Blood Volume Analysis Technology

Daxor’s ezBVA Lab Service Marks New Standard in Precision Fluid Management Oak Ridge, TN, May 07, 2025 (GLOBE NEWSWIRE) — Daxor Corporation (Nasdaq: DXR), the global leader in blood volume measurement technology, today announces the opening of a new BVA program at a premier Florida healthcare center in the Tampa Bay region. This expansion integrates Daxor’s innovative blood volume analysis (BVA) testing across the facility’s inpatient and outpatient care programs, revolutionizing fluid management precision and enhancing treatment outcomes for a spectrum of conditions. The facility will utilize Daxor’s state-of-the-art Tennessee-based CLIA-certified ezBVA Lab that delivers comprehensive blood volume analysis results within 24 hours of sample receipt. “This exciting hallmark marks another significant milestone...

Continue reading

Krystal Biotech to Present at BofA Securities 2025 Health Care Conference

PITTSBURGH, May 07, 2025 (GLOBE NEWSWIRE) — Krystal Biotech, Inc. (the “Company”) (NASDAQ: KRYS) today announced that the Company will participate in the BofA Securities 2025 Health Care Conference on May 14, 2025, in Las Vegas. Krish S. Krishnan, Chairman and Chief Executive Officer, will take part in a fireside chat scheduled at 11:20 am PT and host investor meetings throughout the day. A webcast of the presentation will be available here beginning at 11:20 am PT on Wednesday, May 14, 2025 and will be posted on the Investors section of the Company’s website. About Krystal Biotech, Inc. Krystal Biotech, Inc. (NASDAQ: KRYS) is a fully integrated, commercial-stage, global biotechnology company focused on the discovery, development and commercialization of genetic medicines to treat diseases with high unmet medical needs. VYJUVEK®,...

Continue reading

22nd Century Group Further Reduces Debt by $1.0 Million Following Financing Transaction

Year to Date Total Debt Reduction of approximately $3.8 Million MOCKSVILLE, N.C., May 07, 2025 (GLOBE NEWSWIRE) — 22nd Century Group, Inc. (Nasdaq: XXII), a tobacco products company that is leading the fight against nicotine dependence and believes smokers should have a choice about their nicotine consumption, today announced that has repaid an additional $1 million in debt to its senior lender. The Company’s total debt principal outstanding now stands at approximately $3.9 million. “Our debt reduction progress has been outstanding and total debt principal is now less than $4 million, as compared with approximately $20 million of total debt obligations when I joined the Company in December 2023,” said Larry Firestone, CEO of 22nd Century Group. We are on our way to becoming debt free, which will allow us to focus our resources...

Continue reading

Disc Medicine Reports First Quarter 2025 Financial Results and Provides Business Update

Company remains on track to submit NDA for bitopertin in erythropoietic protoporphyria (EPP) in H2 2025 Initiated APOLLO, a confirmatory clinical trial of bitopertin in adults and adolescents with EPP Plan to initiate Phase 2 study of DISC-3405 in polycythemia vera (PV) in H1 2025 Expect data readouts for DISC-0974 program in H2 2025, including initial results of Phase 2 anemia of myelofibrosis (MF) study and multiple dose data from Phase 1b anemia of non-dialysis dependent chronic kidney disease (NDD-CKD) study Strong financial position supported by $259 million public offering in January 2025; ended Q1 with $695 million in cash, cash equivalents, and marketable securities, which is expected to fund operations into 2028 Company to host virtual MF Anemia KOL Day on Friday, May 9 at 1:00 PM ET / 10:00 AM PTWATERTOWN, Mass., May 07,...

Continue reading

GCM Grosvenor Reports First Quarter 2025 Earnings Results, with Quarter-To-Date Fundraising Increasing 77% Year-Over-Year, Quarter-to-Date GAAP Net Income of $0.5 million, and Fee-Related Earnings and Adjusted Net Income Increasing 22% and 30%, Respectively, Year-Over-Year

CHICAGO, May 07, 2025 (GLOBE NEWSWIRE) — GCM Grosvenor (Nasdaq: GCMG), a global alternative asset management solutions provider, today reported its results for the first quarter 2025. GCM Grosvenor issued a detailed presentation of its results to the Public Shareholders section of GCM Grosvenor’s website at https://www.gcmgrosvenor.com/shareholder-events. GCM Grosvenor’s Board of Directors approved a $0.11 per share dividend payable on June 16, 2025 to shareholders on record June 6, 2025. Conference CallA conference call to discuss GCM Grosvenor’s financial results will be held today, Wednesday, May 7, 2025, at 10:00 a.m. ET. The call will be accessible via public webcast from the Public Shareholders section of GCM Grosvenor’s website at https://www.gcmgrosvenor.com/shareholder-events, and a replay of the live broadcast will...

Continue reading

Intermex Reports First-Quarter Results

Company reports solid volume growth, continued execution of omnichannel strategy Company to Host Conference Call Today at 9 a.m. ET MIAMI, May 07, 2025 (GLOBE NEWSWIRE) — International Money Express, Inc. (NASDAQ: IMXI) (“Intermex” or the “Company”), one of the nation’s leading global omnichannel money transfer services to Latin America and the Caribbean, today reported financial and operating results for the first quarter of 2025. Financial performance highlights for the first quarter of 2025:Revenues of $144.3 million Net income of $7.8 million Diluted EPS of $0.25 Adjusted Diluted EPS of $0.35 Adjusted EBITDA of $21.6 millionBob Lisy, Chairman, President, and CEO of Intermex, stated “Intermex’s first quarter results reflect the strength and discipline of the Intermex business model, despite an economic and political...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.